Instrument Inactif

Communiqués Mymetics Corp OTC Bulletin Board

Actions

US62856A1025

Recherche biotechnologique et médicale

Communiqués

11/04/23	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
27/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
08/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
17/01/23	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
28/12/22	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
14/11/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
11/08/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
13/05/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
04/04/22	MYMETICS CORP - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
31/03/22	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
12/11/21	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/08/21	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
17/06/21	MYMETICS CORP : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
31/03/21	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
23/03/21	Mymetics : Amendment to Quarterly Report (SEC Filing - 10-Q/A)	PU
23/03/21	Mymetics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
18/11/20	Mymetics : to advance Preclinical Studies for Virosome-based Covid-19 Vaccine through Innosuisse grant	PU
13/11/20	Mymetics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
02/11/20	Mymetics : Starts Second Preclinical Study for Virosome-based Covid-19 vaccine	PU
15/05/20	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
30/03/20	MYMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
07/01/20	MYMETICS CORP : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
11/04/16	Mymetics' : HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute	MW
11/04/16	Mymetics' : HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute	MW
05/04/16	Mymetics : Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate	MW